A health-focused international venture capital firm is one of three new investors in Chinese krill-processing firm Function (Qingdao) Marine Technology.
As a health-focused firm describing itself as “a global venture capital platform investing in startups positively impacting the world through technology,” Cathay Innovations is part of the Cathay Capital group with offices in China, Europe, and the U.S.
Another investor in Function is China Railway Construction Investment Group – the venture capital arm of the state-owned company that builds and operates railways both domestically and abroad.
The third investor is another state-owned firm: Shandong Health Group. The company has made large investments in elder care facilities across China’s east coast.
Function, also trading as Fengshi Technology, is a major purchaser of krill oil from ...
Photo courtesy of HNC Health and Nutrition Exhibition
